BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

957 related articles for article (PubMed ID: 20180725)

  • 1. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
    Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis use in patients with a first psychotic episode and subjects at ultra high risk of psychosis: impact on psychotic- and pre-psychotic symptoms.
    Machielsen M; van der Sluis S; de Haan L
    Aust N Z J Psychiatry; 2010 Aug; 44(8):721-8. PubMed ID: 20636193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subjective effects of cannabis before the first psychotic episode.
    Peters BD; de Koning P; Dingemans P; Becker H; Linszen DH; de Haan L
    Aust N Z J Psychiatry; 2009 Dec; 43(12):1155-62. PubMed ID: 20001415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cannabis use on event related potentials in subjects at ultra high risk for psychosis and healthy controls.
    van Tricht MJ; Harmsen EC; Koelman JH; Bour LJ; van Amelsvoort TA; Linszen DH; de Haan L; Nieman DH
    Int J Psychophysiol; 2013 May; 88(2):149-56. PubMed ID: 23541998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive functioning in children and adolescents in their first episode of psychosis: differences between previous cannabis users and nonusers.
    de la Serna E; Mayoral M; Baeza I; Arango C; Andrés P; Bombin I; González C; Rapado M; Robles O; Rodríguez-Sánchez JM; Zabala A; Castro-Fornieles J
    J Nerv Ment Dis; 2010 Feb; 198(2):159-62. PubMed ID: 20145493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.
    Meijer JH; Dekker N; Koeter MW; Quee PJ; van Beveren NJ; Meijer CJ;
    Psychol Med; 2012 Apr; 42(4):705-16. PubMed ID: 21899795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and neurocognitive profiles of subjects at high risk for psychosis with and without obsessive-compulsive symptoms.
    Hur JW; Shin NY; Jang JH; Shim G; Park HY; Hwang JY; Kim SN; Yoo JH; Hong KS; Kwon JS
    Aust N Z J Psychiatry; 2012 Feb; 46(2):161-9. PubMed ID: 22311532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caudate nucleus volume in individuals at ultra-high risk of psychosis: a cross-sectional magnetic resonance imaging study.
    Hannan KL; Wood SJ; Yung AR; Velakoulis D; Phillips LJ; Soulsby B; Berger G; McGorry PD; Pantelis C
    Psychiatry Res; 2010 Jun; 182(3):223-30. PubMed ID: 20488675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls.
    Jockers-Scherübl MC; Wolf T; Radzei N; Schlattmann P; Rentzsch J; Gómez-Carrillo de Castro A; Kühl KP
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1054-63. PubMed ID: 17482741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia.
    Ringen PA; Vaskinn A; Sundet K; Engh JA; Jónsdóttir H; Simonsen C; Friis S; Opjordsmoen S; Melle I; Andreassen OA
    Psychol Med; 2010 Aug; 40(8):1337-47. PubMed ID: 19891810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study.
    Degenhardt L; Tennant C; Gilmour S; Schofield D; Nash L; Hall W; McKay D
    Psychol Med; 2007 Jul; 37(7):927-34. PubMed ID: 17288638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal patterns of social functioning and conversion to psychosis in subjects at ultra-high risk.
    Jang JH; Shin NY; Shim G; Park HY; Kim E; Jang GE; Kwon SJ; Hur JW; An SK; Kwon JS
    Aust N Z J Psychiatry; 2011 Sep; 45(9):763-70. PubMed ID: 21827349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
    Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
    Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive functioning before and after the first psychotic episode: does psychosis result in cognitive deterioration?
    Becker HE; Nieman DH; Wiltink S; Dingemans PM; van de Fliert JR; Velthorst E; de Haan L; van Amelsvoort TA; Linszen DH
    Psychol Med; 2010 Oct; 40(10):1599-606. PubMed ID: 20132582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.
    Velthorst E; Nieman DH; Becker HE; van de Fliert R; Dingemans PM; Klaassen R; de Haan L; van Amelsvoort T; Linszen DH
    Schizophr Res; 2009 Apr; 109(1-3):60-5. PubMed ID: 19272756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The history of childhood trauma among individuals with ultra high risk for psychosis is as common as among patients with first-episode schizophrenia.
    Sahin S; Yüksel Ç; Güler J; Karadayı G; Akturan E; Göde E; Özhan AA; Üçok A
    Early Interv Psychiatry; 2013 Nov; 7(4):414-20. PubMed ID: 23343404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?
    Bang M; Kim KR; Song YY; Baek S; Lee E; An SK
    Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.